| Date | Company | Amount | Funding type | Investors | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2012-07-10 | Integragen (France) | €2 million | capital increase | funds managed by A Plus Finance. | Cancer - Oncology - CNS diseases - Psychiatric diseases | Capital increase |
| 2012-07-09 | Genkyotex (Switzerland) | CHF25 million ($26 million - €20.8 million) | series C financing round | Edmond de Rothschild Investment Partners (EdRIP) (France) Vesalius Biocapital Partners (Luxembourg) MP Healthcare Venture Management (USA) Eclosion (Switzerland) |
Fundraising | |
| 2012-07-05 | Psioxus Therapeutics (UK) | £ 22 million ($ 34 million - € 27.7 million) | series B round | Lundbeckfond Ventures (Denmark) - SR One (UK) - Invesco Perpetual (UK) - Imperial Innovations (UK) | Cancer - Oncology | Fundraising |
| 2012-07-03 | Genfit (France) | € 500 000 | capital increase | undisclosed historical shareholder | Cardiovascular diseases - Metabolic diseases - Liver diseases | Capital increase |
| 2012-07-02 | Medicyte (Germany) | €4.2 million | grant | Regenerative medicine - Liver diseases | Grant | |
| 2012-06-29 | Galapagos (Belgium) | capital increase through warrant exercises | Galapagos\' employees | Technology - Services | Capital increase | |
| 2012-06-29 | MDxHealth (Belgium) | € 10 million | private placement of new shares | Cancer - Oncology | Private placement | |
| 2012-06-29 | Oxford Biomedica (UK) | up to £16 million | private placement | Ophtalmological diseases - Rare diseases - Genetic diseases | Private placement | |
| 2012-06-29 | Mimetas (The Netherlands) | € 200 000 | grant | Dutch Foundation for Applied Sciences (STW) (The Netherlands) | Technology - Services | Grant |
| 2012-06-19 | Nuevolution (Denmark) | € 11 million (DKK 80.5 million) | financing round | Industrifonden (Sweden) - Sunstone Capital (Denmark) - SEB Venture Capital (Sweden) - SEB Utvecklingsstiftelse | Technology - Services | Fundraising |
| 2012-06-19 | Xenikos (The Netherlands) | € 5.5 million | series A financing round | Sanquin Blood Supply Foundation (The Netherlands) Participatiemaatschappij Oost Nederland N.V (The Netherlands) Innovation & Investment Fund Gelderland (The Netherlands) Agentschap NL (The Netherlands) |
Transplantation - Immunological diseases | Fundraising |
| 2012-06-18 | Oxford Immunotec (UK) | $28 million (€ 22.1 million) | financing round | Imperial Innovations (UK) - Invesco Perpetual (UK) - Clarus Ventures (USA) - New Leaf (USA) - DFJ Esprit (UK) - Wellington Partners (USA) - Kaiser Permanente Ventures (USA) - SPARK Ventures (UK) - the University of Oxford (OSEM) (UK) | Immunological diseases | Fundraising |
| 2012-06-18 | Calixar (France) | € 875,000 euros | initial funding round | INPG Entreprise (France) - Siparex (France) - Veymont Participations (France) - regional business angels from the Health-Angels Rhône-Alpes, Savoie Angels and Grenoble Angels networks (France) | Technology - Services | Fundraising |
| 2012-06-05 | Exonhit (France) | € 1.93 million | grants and redeemable advances | OSEO (France) | Cancer - Oncology | Grant |
| 2012-06-05 | Erytech Pharma (France) | € 6.95 million | grants and redeemable advances | OSEO (France) | Cancer - Oncology | Grant |
| 2012-06-04 | Alize Pharma (France) | € 3.3 million | financing round | Sham (France) - OCTALFA (France) - CEMA (Canada) - Thierry Abribat (founder and president) | Cancer - Oncology - Metabolic diseases - Rare diseases | Financing round |
| 2012-06-04 | Telormedix (Switzerland) Foamix (Israel) | € 950,000 | grant | European Eurostars Programme (EU) | Cancer - Oncology - Inflammatory diseases | Grant |
| 2012-05-23 | Thrombogenics (Belgium) | €1.383.132,05 | capital increase from employee warrant exercises | employees | Ophtalmological diseases | Capital increase |
| 2012-05-22 | Prothix (The Netherlands), Bioceros (The Netherlands), Antitope (UK),The University Medical Center of Utrecht (The Netherlands) | €1.6 million | grant | Eureka Eurostars program | Grant | |
| 2012-05-21 | ElexoPharm (Germany) | € 2.1 Million | grant | German Federal Ministry of Education and Research (BMBF) (Germany) European Commission |
Mitochondrial diseases | Grant |
